Intraoperative floppy iris syndrome: updated perspectives
CD Christou, I Tsinopoulos, N Ziakas… - Clinical …, 2020 - Taylor & Francis
Almost fifteen years since its initial description, intraoperative floppy iris syndrome (IFIS)
during phacoemulsification surgery remains a challenge for cataract surgeons in all its key …
during phacoemulsification surgery remains a challenge for cataract surgeons in all its key …
[HTML][HTML] A narrative review of intraoperative floppy iris syndrome: an update 2020
X Yang, Z Liu, Z Fan, A Grzybowski… - Annals of Translational …, 2020 - ncbi.nlm.nih.gov
Intraoperative floppy iris syndrome (IFIS) is characterized by intraoperative floppiness or
billowing of the iris, progressive miosis, and iris prolapse through the surgical wounds. It was …
billowing of the iris, progressive miosis, and iris prolapse through the surgical wounds. It was …
Choroidal evaluation in patients under alpha-lytic therapy
M De Bernardo, V Altieri, A Coppola, M Gioia… - Graefe's Archive for …, 2020 - Springer
Purpose To detect any choroidal thickness (CT) change in patients after alpha-lytic drugs
withdrawal that could help in the cataract surgery timing decision. Methods Twenty-five eyes …
withdrawal that could help in the cataract surgery timing decision. Methods Twenty-five eyes …
The effect of systemic and topical ophthalmic medications on choroidal thickness: a review
The choroid plays an important role in various ocular pathologies and retinal blood supply.
There is a knowledge gap on how the choroid is affected by systemic and topical …
There is a knowledge gap on how the choroid is affected by systemic and topical …
Intraoperative floppy iris syndrome: an updated review of literature
Intraoperative Floppy iris syndrome (IFIS) remains a challenge for surgeons during
phacoemulsification. Initially, it was related to the use of tamsulosin, an alpha adrenergic …
phacoemulsification. Initially, it was related to the use of tamsulosin, an alpha adrenergic …
Risk of intraoperative floppy iris syndrome among selective alpha-1 blockers—A consistency model of 6,488 cases
YH Wang, LC Huang, SHL Tsai, YJ Chen… - Frontiers in …, 2022 - frontiersin.org
Selective α1-blockers are commonly administered to patients with lower urinary tract
syndrome and benign prostatic hyperplasia, but may increase the risk of intraoperative …
syndrome and benign prostatic hyperplasia, but may increase the risk of intraoperative …
[HTML][HTML] Effects of Alpha-Lytic Therapy Withdrawal on Choroidal Parameters in Intraoperative Floppy Iris Syndrome High-Risk Patients
M Gioia, M De Bernardo, M De Luca… - Journal of Clinical …, 2024 - mdpi.com
Background/Objectives: The aim of this study is to investigate the effect on choroidal
parameters of drug withdrawal in patients taking α1 adrenergic receptor antagonist (ARA) …
parameters of drug withdrawal in patients taking α1 adrenergic receptor antagonist (ARA) …
The relationship between quantitative pupillometry and estimated ganglion cell counts in patients with glaucoma
DS Chang, K Arora, MV Boland… - Journal of …, 2019 - journals.lww.com
Purpose: To assess the relationship between pupillary light reflex and estimated retinal
ganglion cell (RGC) counts in patients with glaucoma. Methods: We recorded and analyzed …
ganglion cell (RGC) counts in patients with glaucoma. Methods: We recorded and analyzed …
Prospective analysis of anatomic features predisposing patients to intraoperative floppy iris syndrome
K Paschon, S Szegedi, B Weingessel, K Fondi… - Graefe's Archive for …, 2024 - Springer
Purpose To aid preoperative risk assessment by identifying anatomic parameters
corresponding with a higher risk of intraoperative floppy iris syndrome (IFIS) during cataract …
corresponding with a higher risk of intraoperative floppy iris syndrome (IFIS) during cataract …
[HTML][HTML] Intraoperative Iris Behavior during Phacoemulsification Maneuvers in Rabbits Treated with Selective α1-Blocker, 5α-Reductase Inhibitor, or Anxiolytic …
This prospective, experimental study aims to evaluate the association between
administration of α-blocker, 5α-reductase inhibitor, or anxiolytic medications and …
administration of α-blocker, 5α-reductase inhibitor, or anxiolytic medications and …